Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 192 entries
Sorted by: Best Match Show Resources per page
Enhancing a blended module in general didactics: New contents, materials, forms of assessment and feedback

instructional innovation

Bassi F, Zuccoli F.
GSID: jzE3a2q5_TIJ
L Teruggi, F Zuccoli, F Bassi - Form@ re-Open …, 2019 - rivistadistoriadelleducazione.it

Il presente contributo vuole presentare una riflessione sull'evoluzione del corso di Didattica Generale, del Corso di Laurea in Scienze della Formazione Primaria, Università di Milano …

Cite
Teruggi, L., Zuccoli, F., & Bassi, F. (2019). Enhancing a blended module in general didactics: New contents, materials, forms of assessment and feedback. Form@ re-Open Journal per la formazione in rete, 19(3), 257-266.
Teruggi, Lilia, Franca Zuccoli, and Francesca Bassi. "Enhancing a blended module in general didactics: New contents, materials, forms of assessment and feedback." Form@ re-Open Journal per la formazione in rete 19.3 (2019): 257-266.
Copy Download .nbib Format: MLA
Medical conference by computer.

M.D. computing : computers in medical practice

Zucconi G.
PMID: 3574031
MD Comput. 1986 Mar-Apr;3(2):40-3.

No abstract available.

Cite
Zucconi G. Medical conference by computer. MD Comput. 1986;3(2):40-3
Zucconi, G. (1986). Medical conference by computer. M.D. computing : computers in medical practice, 3(2), 40-3.
Zucconi, G. "Medical conference by computer." M.D. computing : computers in medical practice vol. 3,2 (1986): 40-3.
Zucconi G. Medical conference by computer. MD Comput. 1986 Mar-Apr;3(2):40-3. PMID: 3574031.
Copy Download .nbib Format: NLM
Approval rating and opinion of outpatients and general practitioners toward generic drugs: a questionnaire-based real-world study.

Patient preference and adherence

Mattioli F, Siri G, Castelli F, Puntoni M, Zuccoli ML, Stimamiglio A, Martelli A.
PMID: 28860725
Patient Prefer Adherence. 2017 Aug 18;11:1423-1433. doi: 10.2147/PPA.S126486. eCollection 2017.

PURPOSE: Generic drugs use in the Liguria region is higher than the Italian average, but lower than in other European countries. No data exist about real-life prescription and level of awareness of generic drugs. In this study, we analyzed...

Cite
Mattioli F, Siri G, Castelli F, et al. Approval rating and opinion of outpatients and general practitioners toward generic drugs: a questionnaire-based real-world study. Patient Prefer Adherence. 2017;11:1423-1433doi: 10.2147/PPA.S126486.
Mattioli, F., Siri, G., Castelli, F., Puntoni, M., Zuccoli, M. L., Stimamiglio, A., & Martelli, A. (2017). Approval rating and opinion of outpatients and general practitioners toward generic drugs: a questionnaire-based real-world study. Patient preference and adherence, 111423-1433. https://doi.org/10.2147/PPA.S126486
Mattioli, F, et al. "Approval rating and opinion of outpatients and general practitioners toward generic drugs: a questionnaire-based real-world study." Patient preference and adherence vol. 11 (2017): 1423-1433. doi: https://doi.org/10.2147/PPA.S126486
Mattioli F, Siri G, Castelli F, Puntoni M, Zuccoli ML, Stimamiglio A, Martelli A. Approval rating and opinion of outpatients and general practitioners toward generic drugs: a questionnaire-based real-world study. Patient Prefer Adherence. 2017 Aug 18;11:1423-1433. doi: 10.2147/PPA.S126486. eCollection 2017. PMID: 28860725; PMCID: PMC5572951.
Copy Download .nbib Format: NLM
Ammonia Borane Dehydrogenation Catalyzed by (κ.

Inorganic chemistry

Todisco S, Luconi L, Giambastiani G, Rossin A, Peruzzini M, Golub IE, Filippov OA, Belkova NV, Shubina ES.
PMID: 28345899
Inorg Chem. 2017 Apr 17;56(8):4296-4307. doi: 10.1021/acs.inorgchem.6b02673. Epub 2017 Mar 27.

Two Co(I) hydrides containing the tripodal polyphosphine ligand EP

Cite
Todisco S, Luconi L, Giambastiani G, et al. Ammonia Borane Dehydrogenation Catalyzed by (κ. Inorg Chem. 2017;56(8):4296-4307doi: 10.1021/acs.inorgchem.6b02673.
Todisco, S., Luconi, L., Giambastiani, G., Rossin, A., Peruzzini, M., Golub, I. E., Filippov, O. A., Belkova, N. V., & Shubina, E. S. (2017). Ammonia Borane Dehydrogenation Catalyzed by (κ. Inorganic chemistry, 56(8), 4296-4307. https://doi.org/10.1021/acs.inorgchem.6b02673
Todisco, Stefano, et al. "Ammonia Borane Dehydrogenation Catalyzed by (κ." Inorganic chemistry vol. 56,8 (2017): 4296-4307. doi: https://doi.org/10.1021/acs.inorgchem.6b02673
Todisco S, Luconi L, Giambastiani G, Rossin A, Peruzzini M, Golub IE, Filippov OA, Belkova NV, Shubina ES. Ammonia Borane Dehydrogenation Catalyzed by (κ. Inorg Chem. 2017 Apr 17;56(8):4296-4307. doi: 10.1021/acs.inorgchem.6b02673. Epub 2017 Mar 27. PMID: 28345899.
Copy Download .nbib Format: NLM
Label-free near-infrared reflectance microscopy as a complimentary tool for two-photon fluorescence brain imaging.

Biomedical optics express

Allegra Mascaro AL, Costantini I, Margoni E, Iannello G, Bria A, Sacconi L, Pavone FS.
PMID: 26601011
Biomed Opt Express. 2015 Oct 21;6(11):4483-92. doi: 10.1364/BOE.6.004483. eCollection 2015 Nov 01.

In vivo two-photon imaging combined with targeted fluorescent indicators is currently extensively used for attaining critical insights into brain functionality and structural plasticity. Additional information might be gained from back-scattered photons from the near-infrared (NIR) laser without introducing any...

Cite
Allegra Mascaro AL, Costantini I, Margoni E, et al. Label-free near-infrared reflectance microscopy as a complimentary tool for two-photon fluorescence brain imaging. Biomed Opt Express. 2015;6(11):4483-92doi: 10.1364/BOE.6.004483.
Allegra Mascaro, A. L., Costantini, I., Margoni, E., Iannello, G., Bria, A., Sacconi, L., & Pavone, F. S. (2015). Label-free near-infrared reflectance microscopy as a complimentary tool for two-photon fluorescence brain imaging. Biomedical optics express, 6(11), 4483-92. https://doi.org/10.1364/BOE.6.004483
Allegra Mascaro, Anna Letizia, et al. "Label-free near-infrared reflectance microscopy as a complimentary tool for two-photon fluorescence brain imaging." Biomedical optics express vol. 6,11 (2015): 4483-92. doi: https://doi.org/10.1364/BOE.6.004483
Allegra Mascaro AL, Costantini I, Margoni E, Iannello G, Bria A, Sacconi L, Pavone FS. Label-free near-infrared reflectance microscopy as a complimentary tool for two-photon fluorescence brain imaging. Biomed Opt Express. 2015 Oct 21;6(11):4483-92. doi: 10.1364/BOE.6.004483. eCollection 2015 Nov 01. PMID: 26601011; PMCID: PMC4646555.
Copy Download .nbib Format: NLM
Warfarin-related nephropathy: possible role for the warfarin pharmacogenetic profile.

Clinical kidney journal

Di Maso V, Carraro M, Bevilacqua E, Bucconi S, Artero ML, Boscutti G.
PMID: 25859382
Clin Kidney J. 2014 Dec;7(6):605-8. doi: 10.1093/ckj/sfu112. Epub 2014 Oct 28.

Warfarin-related nephropathy (WRN) is a renal complication of warfarin treatment associated with over-anticoagulation. We describe a case of a 73-year-old man affected by chronic kidney disease, essential hypertension and atrial fibrillation treated with warfarin. The patient presented a rapid...

Cite
Di Maso V, Carraro M, Bevilacqua E, et al. Warfarin-related nephropathy: possible role for the warfarin pharmacogenetic profile. Clin Kidney J. 2014;7(6):605-8doi: 10.1093/ckj/sfu112.
Di Maso, V., Carraro, M., Bevilacqua, E., Bucconi, S., Artero, M. L., & Boscutti, G. (2014). Warfarin-related nephropathy: possible role for the warfarin pharmacogenetic profile. Clinical kidney journal, 7(6), 605-8. https://doi.org/10.1093/ckj/sfu112
Di Maso, Vittorio, et al. "Warfarin-related nephropathy: possible role for the warfarin pharmacogenetic profile." Clinical kidney journal vol. 7,6 (2014): 605-8. doi: https://doi.org/10.1093/ckj/sfu112
Di Maso V, Carraro M, Bevilacqua E, Bucconi S, Artero ML, Boscutti G. Warfarin-related nephropathy: possible role for the warfarin pharmacogenetic profile. Clin Kidney J. 2014 Dec;7(6):605-8. doi: 10.1093/ckj/sfu112. Epub 2014 Oct 28. PMID: 25859382; PMCID: PMC4389147.
Copy Download .nbib Format: NLM
Phase II Study of Bortezomib as a Single Agent in Patients with Previously Untreated or Relapsed/Refractory Acute Myeloid Leukemia Ineligible for Intensive Therapy.

Leukemia research and treatment

Sarlo C, Buccisano F, Maurillo L, Cefalo M, Di Caprio L, Cicconi L, Ditto C, Ottaviani L, Di Veroli A, Del Principe MI, Grasso MA, Nasso D, De Santis G, Amadori S, Venditti A.
PMID: 23738080
Leuk Res Treatment. 2013;2013:705714. doi: 10.1155/2013/705714. Epub 2013 Apr 28.

We explored the safety and efficacy of bortezomib given as single agent in patients with untreated or relapsed/refractory acute myeloid leukemia (AML), unfit for conventional chemotherapy. Fourteen patients were treated with bortezomib 1.5 mg/m(2) administered twice weekly for two...

Cite
Sarlo C, Buccisano F, Maurillo L, et al. Phase II Study of Bortezomib as a Single Agent in Patients with Previously Untreated or Relapsed/Refractory Acute Myeloid Leukemia Ineligible for Intensive Therapy. Leuk Res Treatment. 2013;2013:705714doi: 10.1155/2013/705714.
Sarlo, C., Buccisano, F., Maurillo, L., Cefalo, M., Di Caprio, L., Cicconi, L., Ditto, C., Ottaviani, L., Di Veroli, A., Del Principe, M. I., Grasso, M. A., Nasso, D., De Santis, G., Amadori, S., & Venditti, A. (2013). Phase II Study of Bortezomib as a Single Agent in Patients with Previously Untreated or Relapsed/Refractory Acute Myeloid Leukemia Ineligible for Intensive Therapy. Leukemia research and treatment, 2013705714. https://doi.org/10.1155/2013/705714
Sarlo, Chiara, et al. "Phase II Study of Bortezomib as a Single Agent in Patients with Previously Untreated or Relapsed/Refractory Acute Myeloid Leukemia Ineligible for Intensive Therapy." Leukemia research and treatment vol. 2013 (2013): 705714. doi: https://doi.org/10.1155/2013/705714
Sarlo C, Buccisano F, Maurillo L, Cefalo M, Di Caprio L, Cicconi L, Ditto C, Ottaviani L, Di Veroli A, Del Principe MI, Grasso MA, Nasso D, De Santis G, Amadori S, Venditti A. Phase II Study of Bortezomib as a Single Agent in Patients with Previously Untreated or Relapsed/Refractory Acute Myeloid Leukemia Ineligible for Intensive Therapy. Leuk Res Treatment. 2013;2013:705714. doi: 10.1155/2013/705714. Epub 2013 Apr 28. PMID: 23738080; PMCID: PMC3655652.
Copy Download .nbib Format: NLM
[Fractures of the mandible in children and treatment].

Archivio italiano di chirurgia

RUSCONI L, AMADEI A.
PMID: 14800606
Arch Ital Chir. 1950;73(6):375-418.

No abstract available.

Cite
RUSCONI L, AMADEI A. Le fratture della mandibola nei bambini e loro trattamento. [Fractures of the mandible in children and treatment]. Arch Ital Chir. 1950;73(6):375-418
RUSCONI, L., & AMADEI, A. (1950). Le fratture della mandibola nei bambini e loro trattamento. [Fractures of the mandible in children and treatment]. Archivio italiano di chirurgia, 73(6), 375-418.
RUSCONI, L, and AMADEI, A. "Le fratture della mandibola nei bambini e loro trattamento." [Fractures of the mandible in children and treatment]. Archivio italiano di chirurgia vol. 73,6 (1950): 375-418.
RUSCONI L, AMADEI A. Le fratture della mandibola nei bambini e loro trattamento. [Fractures of the mandible in children and treatment]. Arch Ital Chir. 1950;73(6):375-418. Undetermined. PMID: 14800606.
Copy Download .nbib Format: NLM
Do dopaminergic agents increase the daytime sleep propensity? Article reviewed: Effect of ropinirole on sleep onset. A randomized, placebo-controlled study in healthy volunteers.

Sleep medicine

Zucconi M.
PMID: 14592182
Sleep Med. 2002 Sep;3(5):445-6. doi: 10.1016/s1389-9457(02)00104-1.

No abstract available.

Cite
Zucconi M. Do dopaminergic agents increase the daytime sleep propensity? Article reviewed: Effect of ropinirole on sleep onset. A randomized, placebo-controlled study in healthy volunteers. Sleep Med. 2002;3(5):445-6doi: 10.1016/s1389-9457(02)00104-1.
Zucconi, M. (2002). Do dopaminergic agents increase the daytime sleep propensity? Article reviewed: Effect of ropinirole on sleep onset. A randomized, placebo-controlled study in healthy volunteers. Sleep medicine, 3(5), 445-6. https://doi.org/10.1016/s1389-9457(02)00104-1
Zucconi, Marco. "Do dopaminergic agents increase the daytime sleep propensity? Article reviewed: Effect of ropinirole on sleep onset. A randomized, placebo-controlled study in healthy volunteers." Sleep medicine vol. 3,5 (2002): 445-6. doi: https://doi.org/10.1016/s1389-9457(02)00104-1
Zucconi M. Do dopaminergic agents increase the daytime sleep propensity? Article reviewed: Effect of ropinirole on sleep onset. A randomized, placebo-controlled study in healthy volunteers. Sleep Med. 2002 Sep;3(5):445-6. doi: 10.1016/s1389-9457(02)00104-1. PMID: 14592182.
Copy Download .nbib Format: NLM
Article reviewed: Familial advanced sleep phase syndrome.

Sleep medicine

Zucconi M.
PMID: 14592240
Sleep Med. 2002 Mar;3(2):177-8. doi: 10.1016/s1389-9457(02)00020-5.

No abstract available.

Cite
Zucconi M. Article reviewed: Familial advanced sleep phase syndrome. Sleep Med. 2002;3(2):177-8doi: 10.1016/s1389-9457(02)00020-5.
Zucconi, M. (2002). Article reviewed: Familial advanced sleep phase syndrome. Sleep medicine, 3(2), 177-8. https://doi.org/10.1016/s1389-9457(02)00020-5
Zucconi, Marco. "Article reviewed: Familial advanced sleep phase syndrome." Sleep medicine vol. 3,2 (2002): 177-8. doi: https://doi.org/10.1016/s1389-9457(02)00020-5
Zucconi M. Article reviewed: Familial advanced sleep phase syndrome. Sleep Med. 2002 Mar;3(2):177-8. doi: 10.1016/s1389-9457(02)00020-5. PMID: 14592240.
Copy Download .nbib Format: NLM
Reversible posterior leukoencephalopathy associated with postpartum HELLP syndrome.

European journal of internal medicine

Negro A, Zuccoli G, Regolisti G, Mastrangeli S, Rossi E.
PMID: 16084357
Eur J Intern Med. 2005 Aug;16(4):291-3. doi: 10.1016/j.ejim.2004.11.010.

We describe a case of a severe, immediate postpartum HELLP syndrome (hemolysis, elevated liver enzyme levels, low platelet count) with reversible posterior leukoencephalopathy (RPLS) characterized by generalized seizure, altered mental status, and visual loss in a 37-year-old primigravid woman....

Cite
Negro A, Zuccoli G, Regolisti G, et al. Reversible posterior leukoencephalopathy associated with postpartum HELLP syndrome. Eur J Intern Med. 2005;16(4):291-3doi: 10.1016/j.ejim.2004.11.010.
Negro, A., Zuccoli, G., Regolisti, G., Mastrangeli, S., & Rossi, E. (2005). Reversible posterior leukoencephalopathy associated with postpartum HELLP syndrome. European journal of internal medicine, 16(4), 291-3. https://doi.org/10.1016/j.ejim.2004.11.010
Negro, Aurelio, et al. "Reversible posterior leukoencephalopathy associated with postpartum HELLP syndrome." European journal of internal medicine vol. 16,4 (2005): 291-3. doi: https://doi.org/10.1016/j.ejim.2004.11.010
Negro A, Zuccoli G, Regolisti G, Mastrangeli S, Rossi E. Reversible posterior leukoencephalopathy associated with postpartum HELLP syndrome. Eur J Intern Med. 2005 Aug;16(4):291-3. doi: 10.1016/j.ejim.2004.11.010. PMID: 16084357.
Copy Download .nbib Format: NLM
The Ill-fated Child.

The Western journal of medicine

Zucconi G.
PMID: 18750849
West J Med. 1991 Dec;155(6):664-5.

No abstract available.

Cite
Zucconi G. The Ill-fated Child. West J Med. 1991;155(6):664-5
Zucconi, G. (1991). The Ill-fated Child. The Western journal of medicine, 155(6), 664-5.
Zucconi, G. "The Ill-fated Child." The Western journal of medicine vol. 155,6 (1991): 664-5.
Zucconi G. The Ill-fated Child. West J Med. 1991 Dec;155(6):664-5. PMID: 18750849; PMCID: PMC1003133.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 192 entries